Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Ichiro NAKAYAMA"'
Autor:
Yoshihiro Sowa, MD, PhD, Ichiro Nakayama, MD, Yoshihiro Toyohara, MD, Shino Higai, MD, Kotaro Yoshimura, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 6, p e5909 (2024)
Background:. Chronic pain is relatively common after breast cancer surgery, including breast reconstruction. Autologous fat grafting (AFG) has gained attention as a novel method for breast reconstruction, and recent clinical studies have also shown e
Externí odkaz:
https://doaj.org/article/f446fcdae721482a93a0e6d01dedb6e6
Autor:
Yoshihiro Sowa, MD, PhD, Ichiro Nakayama, MD, Ataru Sunaga, MD, Yuya Morishita, MD, Yoshihiro Toyohara, MD, Kotaro Yoshimura, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 12, p e5441 (2023)
Summary:. Lymphaticovenous anastomosis (LVA), which involves connecting lymphatic vessels to veins under a microscope, is widely performed around the world as a surgical treatment for lymphedema due to its relatively low patient burden and consistent
Externí odkaz:
https://doaj.org/article/fd5efd6495e941ae8b253d7d4799fc2a
Autor:
Yoji Nakamura, Naobumi Sasaki, Masahiro Kobayashi, Nobuhiko Ojima, Motoshige Yasuike, Yuya Shigenobu, Masataka Satomi, Yoshiya Fukuma, Koji Shiwaku, Atsumi Tsujimoto, Takanori Kobayashi, Ichiro Nakayama, Fuminari Ito, Kazuhiro Nakajima, Motohiko Sano, Tokio Wada, Satoru Kuhara, Kiyoshi Inouye, Takashi Gojobori, Kazuho Ikeo
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e57122 (2013)
Nori, a marine red alga, is one of the most profitable mariculture crops in the world. However, the biological properties of this macroalga are poorly understood at the molecular level. In this study, we determined the draft genome sequence of susabi
Externí odkaz:
https://doaj.org/article/6846861a15e94aad8f2e70b6b25f00ee
Autor:
Makoto Shiraishi, Yoshihiro Sowa, Itaru Tsuge, Akiko Shiraishi, Naoki Inafuku, Naoki Morimoto, Ichiro Nakayama
Publikováno v:
Surgery Today.
Autor:
Yoshihiro Sowa, Naoki Inafuku, Itaru Tsuge, Hiroki Yamanaka, Motoki Katsube, Michiharu Sakamoto, Ichiro Nakayama, Naoki Morimoto
Publikováno v:
Breast Cancer.
Autor:
Makoto Shiraishi, Yoshihiro Sowa, Itaru Tsuge, Akiko Shiraishi, Naoki Inafuku, Ichiro Nakayama, Naoki Morimoto
Publikováno v:
Breast cancer (Tokyo, Japan). 29(6)
Chronic pain is a major complication following breast surgery including breast reconstruction. We previously examined prospective patient-specific and medical/surgical factors that predict chronic pain a year after breast surgery in the Japanese popu
Autor:
Hiroyasu Yamashiro, Tetsuya Taguchi, Nobuko Ogura, Tomoharu Sugie, Masakazu Toi, Ichiro Nakayama, Hiroshi Ishiguro, Shigeru Tsuyuki, Yuri Fujimoto, Tatsuji Kato, Sachiko Takahara, Hiroshi Yoshibayashi, Masahiro Takada, Tatsuo Kagimura, Yoshio Moriguchi, Kazuhiko Yamagami, Rie Yasuoka, Takeshi Kotake, Hirofumi Suwa, Yuichiro Kikawa, Toshitaka Okuno
Publikováno v:
Cancer Research. 81:PS13-31
BackgroundEribulin (E) is a chemotherapeutic drug that prolongs overall survival (OS) of patients with HER2-negative advanced or metastatic breast cancer (AMBC), mainly in multi-line chemotherapy (ChT) or later. However, the effectiveness and optimal
Autor:
Yuichiro Kikawa, Takeshi Kotake, Shigeru Tsuyuki, Yookija Kang, Sachiko Takahara, Yuri Fujimoto, Hiroyasu Yamashiro, Hiroshi Yoshibayashi, Masahiro Takada, Rie Yasuoka, Katsuhiko Nakatsukasa, Kazuhiko Yamagami, Hirofumi Suwa, Toshitaka Okuno, Ichiro Nakayama, Tatsushi Kato, Nobuko Ogura, Yoshio Moriguchi, Hiroshi Ishiguro, Tatsuo Kagimura, Tetsuya Taguchi, Tomoharu Sugie, Masakazu Toi
Publikováno v:
Breast cancer (Tokyo, Japan). 29(5)
The optimal positioning of eribulin treatment remains unclear. This study aimed to investigate the effectiveness of eribulin administration as first- and second-line chemotherapy in patients with endocrine-resistant advanced or metastatic breast canc
Autor:
Nobuko Ogura, Masakazu Toi, Hiroyasu Yamashiro, Yuichiro Kikawa, Yookija Kang, Katsuhiko Nakatsukasa, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masahiro Takada, Tatsuji Kato, Sachiko Takahara, Hirofumi Suwa, Tatsuo Kagimura, Yoshio Moriguchi, Tomoharu Sugie, Kazuhiko Yamagami, Rie Yasuoka, Yuri Fujimoto, Tetsuya Taguchi, Toshitaka Okuno, Ichiro Nakayama, Takeshi Kotake, Shigeru Tsuyuki
PurposeTo investigate the survival impact of eribulin use in first-line and second-line chemotherapy for patients with endocrine-resistant advanced or metastatic breast cancer (AMBC) in the real-world clinical setting. MethodsThis multi-institutional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a450129b8825cb46485a94ad1cbbc03e
https://doi.org/10.21203/rs.3.rs-412075/v1
https://doi.org/10.21203/rs.3.rs-412075/v1
Publikováno v:
ICES Journal of Marine Science. 77:1480-1491
The relationship between the biomass of Pacific bluefin tuna (PBF) spawners and the amount of recruitment (stock–recruitment relationship, SRR) is unclear. It is likely that environmental effects have masked the SRR of PBF. As the basis of construc